Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dulaglutide

INTERCEPT

Company n/r · Phase n/r · Completed · Enrollment 60000

NCT07417618

ArmPopulationDoseWeeksEstimandWeight change
Initiation of dulaglutide, semaglutide or tirzepatideObesity + T2Dn/rn/rn/rn/r
Initiation of sitagliptinObesity + T2Dn/rn/rn/rn/r